Xuebei An

Intracranial Efficacy and Survival With Tucatinib Plus Trastuzumab and Capecitabine for Previously Treated HER2-Positive Breast Cancer With Brain Metastases in the HER2CLIMB Trial

E. Winer, S. Loi, L. Carey, 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Efficacy and Safety of Parathyroid Hormone Replacement With TransCon PTH in Hypoparathyroidism: 26‐Week Results From the Phase 3 PaTHway Trial

C. Sibley, L. Rejnmark, C. Marcocci, 2022, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

SIFORM: shared informative factor models for integration of multi-platform bioinformatic data

Kim-Anh Do, Jianhua Hu, Xuebei An, 2016, Bioinform..

INTEGRATION OF MULTI-PLATFORM HIGH-DIMENSIONAL OMIC DATA

Xuebei An, Xuebei An, 2016 .

A simulation model of colorectal cancer surveillance and recurrence

Michael W. Kattan, Qingqing Hong, Xuebei An, 2014, BMC Medical Informatics and Decision Making.

Abstract PD13-04: Impact of tucatinib on health-related quality of life in patients with HER2+ metastatic breast cancer with stable and active brain metastases

K. Gelmon, G. Curigliano, D. Cameron, 2021 .

275O Impact of tucatinib on health-related quality of life (HRQoL) in patients with HER2+ metastatic breast cancer (MBC) with and without brain metastases (BM)

K. Gelmon, G. Curigliano, D. Cameron, 2020 .

293P Impact of tucatinib on progression free survival in patients with HER2+ metastatic breast cancer and stable or active brain metastases

G. Hortobagyi, R. Murthy, S. Loibl, 2020 .